Opportunities and challenges for the use of human samples in translational cardiovascular research: a scientific statement of the ESC Working Group on Cellular Biology of the Heart, the ESC Working Group on Cardiovascular Surgery, the ESC Council on Basic Cardiovascular Science, the ESC Scientists of Tomorrow, the European Association of Percutaneous Cardiovascular Interventions of the ESC, and the Heart Failure Association of the ESC

Cardiovascular Research

14 March 2025
Organised by: Logo
ESC Journals Clinical Skills HEART FAILURE Chronic Heart Failure Cardiovascular Surgery Interventional Cardiology VALVULAR, MYOCARDIAL, PERICARDIAL, PULMONARY, CONGENITAL HEART DISEASE Myocardial Disease Valvular Heart Disease BASIC SCIENCE BASICS

Abstract

Abstract

Animal models offer invaluable insights into disease mechanisms but cannot entirely mimic the variability and heterogeneity of human populations, nor the increasing prevalence of multi-morbidity. Consequently, employing human samples—such as whole blood or fractions, valvular and vascular tissues, myocardium, pericardium, or human-derived cells—is essential for enhancing the translational relevance of cardiovascular research. For instance, myocardial tissue slices, which preserve crucial structural and functional characteristics of the human heart, can be used in vitro to examine drug responses. Human blood serves as a rich source of biomarkers, including extracellular vesicles, various types of RNA (miRNA, lncRNA, and circRNAs), circulating inflammatory cells, and endothelial colony-forming cells, facilitating detailed studies of cardiovascular diseases. Primary cardiomyocytes and vascular cells isolated from human tissues are invaluable for mechanistic investigations in vitro. In cases where these are unavailable, human induced pluripotent stem cells serve as effective substitutes, albeit with specific limitations. However, the use of human samples presents challenges such as ethical approvals, tissue procurement and storage, variability in patient genetics and treatment regimens, and the selection of appropriate control samples. Biobanks are central to the efficient use of these scarce and valuable resources. This scientific statement discusses opportunities to implement the use of human samples for cardiovascular research within specific clinical contexts, offers a practical framework for acquiring and utilizing different human materials, and presents examples of human sample applications for specific cardiovascular diseases, providing a valuable resource for clinicians, translational and basic scientists engaged in cardiovascular research.

Contributors

Mariann Gyöngyösi
Mariann Gyöngyösi

Author

Medical University of Vienna Vienna , Austria

Cristina Basso
Cristina Basso

Author

University of Padua Padova , Italy

Petra Kleinbongard
Petra Kleinbongard

Author

University of Duisburg-Essen Medical School Essen , Germany

Gemma Chiva-Blanch
Gemma Chiva-Blanch

Author

University Oberta of Catalunya Barcelona , Spain

Maurizio Pesce
Maurizio Pesce

Author

LUM University Casamassima , Italy

Steffen E Petersen
Steffen E Petersen

Author

Queen Mary University of London London , United Kingdom of Great Britain & Northern Ireland

Sabine Steffens
Sabine Steffens

Author

Institute for Cardiovascular Prevention (IPEK-LMU) Munich , Germany

Sophie Van Linthout
Sophie Van Linthout

Author

Berlin Institute of Health Center for Regenerative Therapies Berlin , Germany

Cinzia Perrino
Cinzia Perrino

Author

University of Naples Federico II Naples , Italy